Laryngeal Mask Airway (LMA) Complication in Children

Completed

• Conditions: Laryngeal Mask Airway
• Interventions: Other: Desflurane; Other: Sevoflurane

• Registration Number: NCT02644226
• Lead Sponsor: Seoul National University Bundang Hospital

Brief Summary

Desflurane is known to be the most pungent of the currently used volatile anesthetics. The investigators tried to find out if desflurane increases the incidence of perioperative upper airway complications in infants and children undergoing general anesthesia using supraglottic airways compared to sevoflurane.

Detailed Description

The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents.

Study Timeline

• Study Start: 2015-11
• Study First Submitted: 2015-12-23
• Study First Submitted QC: 2015-12-29
• Study First Posted: 2015-12-31
• Primary Completion: 2016-01
• Study Completion: 2016-01
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-17
• Last Update Posted: 2016-05-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3528

Inclusion Criteria

• Children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents

Read More

Exclusion Criteria

• Tracheal intubation

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Desflurane	Desflurane	The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using desflurane as maintenance agents.
Sevoflurane	Sevoflurane	The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane as maintenance agents.

Primary Outcome Measures

Name	Time	Method
Occurrence of desaturation	intraoperative
Occurrence of Laryngospasm	intraoperative
Occurrence of Cough	intraoperative

Secondary Outcome Measures

Name	Time	Method
Occurrence of desaturation	through study completion, an average of 1 day
Occurrence of Laryngospasm	through study completion, an average of 1 day
Occurrence of Cough	through study completion, an average of 1 day